Narendra Investments - Eiko Lifesciences Share Price

  • 57.702.37 (4.28%)
  • Volume: 2,228
BSE
  • Live
  • Last Updated On: 30 Aug, 2024, 10:40 AM IST
Loading...

Narendra Investments - ...

  • 57.702.37 (4.28%)
  • Volume: 2,228
Advertisment

Narendra Investments share price insights

  • Company's annual revenue growth of 46.56% outperformed its 3 year CAGR of 30.82%. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 0.79% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Eiko Lifesciences Ltd. share price moved up by 4.28% from its previous close of Rs 55.33. Eiko Lifesciences Ltd. stock last traded price is 57.70

    Share PriceValue
    Today/Current/Last-57.70
    Previous Day-55.33

InsightsNarendra Investments

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    78.78
    EPS - TTM
    (₹)
    0.73
    MCap
    (₹ Cr.)
    80.22
    Sectoral MCap Rank
    167
    PB Ratio
    (x)
    68.88
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month0.19
    3 Months0.14
    6 Months0.07
    1 Year0.03
    3 Years-

    0.19
    VWAP
    (₹)
    57.61
    52W H/L
    (₹)
    81.32 / 45.10

    Narendra Investments Share Price Returns

    1 Day4.28%
    1 Week-1.52%
    1 Month-7.23%
    3 Months15.17%
    1 Year-3.54%
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Narendra Investments belongs to analysts' top-rated companies list?

    View Stock Screeners

    Narendra Investments Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Narendra Investments Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Narendra Investments Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 46.56% outperformed its 3 year CAGR of 30.82%. (Source: Standalone Financials)
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 0.79% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      No reported Profit & Loss Statement are available.

    • No reported Balance Sheet are available.

    • No reported Cash Flow Statement are available.

    • No reported Financial Ratios are available.

    Financial InsightsNarendra Investments

    • Income (P&L)
      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 46.56% outperformed its 3 year CAGR of 30.82%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 0.79% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Narendra Investments Peer Comparison

    • Narendra Investments Stock Performance

    • Ratio Performance

    Peers InsightsNarendra Investments

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Narendra Investments Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Narendra Investments Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters24.4024.2324.2324.23
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others75.6075.7775.7775.77
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters33,82,30924.40 %0.16
        Pledge00.00 %0.00
        Others1,04,78,13675.60 %-0.17

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Narendra Investments Board Meeting/AGM

      • Narendra Investments Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 13, 2024Aug 05, 2024Board MeetingQuarterly Results
        May 13, 2024May 06, 2024Board MeetingAudited Results
        Feb 08, 2024Feb 01, 2024Board MeetingQuarterly Results
        Dec 14, 2023Dec 11, 2023Board MeetingOthers
        Nov 08, 2023Oct 30, 2023Board MeetingQuarterly Results
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final2%0.25Sep 20, 2017Aug 14, 2017
      • All TypesEx-DateRecord DateAnnounced onDetails
        RightsJul 07, 2023Jul 07, 2023Jan 31, 2023Rights ratio: 2 share for every 3 held at a price of Rs 45.0

      About Narendra Investments

      Eiko Lifesciences Ltd., incorporated in the year 1977, is a Small Cap company (having a market cap of Rs 76.37 Crore) operating in Financial Services sector. Eiko Lifesciences Ltd. key Products/Revenue Segments include Speciality Chemicals and Duty Drawback for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • LR

        Laxmikant Ramprasad Kabra

        Chairman & Non-Exe.Director
        LR

        Laxmikant Ramprasad Kabra

        Chairman & Non-Exe.Director
        LR

        Laxmikant Ramprasad Kabra

        Chairman & Non-Exe.Director
        LR

        Laxmikant Ramprasad Kabra

        Chairman & Non-Exe.Director
        Show More
      • Thanawala & Co.
        Shah & Kathariya

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times